Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Cellular and molecular neurobiology

• Publication date

  2021-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10571-021-01148-6PMID 34510330PMCID PMC11441261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2021cited by this paper
• Microglial phagocytosis of neurons in neurodegeneration, and its regulation

  2021cited by this paper
• Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures.

  2021cited by this paper
• Hypoxia and Brain Aging: Neurodegeneration or Neuroprotection?

  2021cited by this paper
• Hypoxia compromises the mitochondrial metabolism of Alzheimer’s disease microglia via HIF1

  2021cited by this paper
• Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.

  2021cited by this paper
• Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response

  2020cited by this paper
• Viral Vector

  2020influential reference
• Intermittent Hypoxia Training for Treating Mild Cognitive Impairment: A Pilot Study

  2020cited by this paper
• Molecular and Therapeutic Aspects of Hyperbaric Oxygen Therapy in Neurological Conditions

  2020cited by this paper
• Alzheimer’s Disease in Patients with Obstructive Sleep Apnea Syndrome

  2020cited by this paper
• The role of hypoxia on Alzheimer's disease-related APP and Tau mRNA formation.

  2020cited by this paper
• Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

  2020cited by this paper
• Overexpression of HIF-2α in Protected Regions of Alzheimer’s disease Resilient Cases

  2020cited by this paper
• Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment

  2020cited by this paper
• Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

  2020cited by this paper
• Overexpression of HIF-2α in Alzheimer's disease Resilient Patients

  2020cited by this paper
• What are the links between hypoxia and Alzheimer’s disease?

  2019cited by this paper
• Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

  2019cited by this paper
• Hypoxia induces HT-22 neuronal cell death via Orai1/CDK5 pathway-mediated Tau hyperphosphorylation.

  2019cited by this paper
• Is Alzheimer's disease an inflammasomopathy?

  2019cited by this paper
• The neuropathological diagnosis of Alzheimer’s disease

  2019cited by this paper
• Building Biological Shields via Hormesis.

  2019cited by this paper
• Amyloid-β-Dependent Inactivation of the Mitochondrial Electron Transport Chain at Low Transmembrane Potential: An Ameliorating Process in Hypoxia-Associated Neurodegenerative Disease?

  2019cited by this paper
• Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2019cited by this paper
• Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume

  2019cited by this paper
• When the Brain Yearns for Oxygen.

  2019cited by this paper
• STAT1 drives M1 microglia activation and neuroinflammation under hypoxia.

  2019cited by this paper
• Microglial phagocytosis in aging and Alzheimer's disease

  2019cited by this paper
• Chronic Intermittent Hypoxia Induces Robust Astrogliosis in an Alzheimer's Disease-Relevant Mouse Model.

  2019cited by this paper
• A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.

  2019cited by this paper
• Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer's disease model mouse.

  2019cited by this paper
• Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.

  2019cited by this paper
• Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets

  2019cited by this paper
• Intermittent hypoxia improves cognition and reduces anxiety‐related behavior in APP/PS1 mice

  2019cited by this paper
• APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction

  2018cited by this paper
• Pathological Impacts of Chronic Hypoxia on Alzheimer's Disease.

  2018cited by this paper
• Conditioning Against the Pathology of Parkinson's disease.

  2018cited by this paper
• Models and methods for conditioning the ischemic brain.

  2018cited by this paper
• Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.

  2018cited by this paper
• Innate immune memory in the brain shapes neurological disease hallmarks

  2018cited by this paper
• Stability analysis of type 2 diabetes mellitus prognosis model with obesity as a trigger factor and metabolic syndrome as a risk factor

  2018cited by this paper
• Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation.

  2018cited by this paper
• Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APPswe/PS1dE9 Mice and Their Wild Type Littermates

  2018cited by this paper
• Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease

  2018cited by this paper
• The Vascular Hypothesis of Alzheimer’s Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging

  2018cited by this paper
• NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease

  2018cited by this paper
• Involvement of impaired autophagy and mitophagy in Neuro-2a cell damage under hypoxic and/or high-glucose conditions

  2018cited by this paper
• Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease.

  2017cited by this paper
• Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.

  2017cited by this paper
• Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging

  2017cited by this paper
• Microglia emerge as central players in brain disease

  2017cited by this paper
• Not just amyloid: physiological functions of the amyloid precursor protein family

  2017cited by this paper
• Cell survival: Interplay between hypoxia and pre-mRNA splicing.

  2017cited by this paper
• Role of hypoxia-inducible factor-1α in autophagic cell death in microglial cells induced by hypoxia

  2017cited by this paper
• The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

  2017cited by this paper
• Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?

  2017cited by this paper
• Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis

  2017cited by this paper
• Preconditioning in neuroprotection: From hypoxia to ischemia.

  2017cited by this paper
• Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates

  2017cited by this paper
• Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early‐stage neurodegeneration

  2017cited by this paper
• Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5

  2017cited by this paper
• Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

  2017cited by this paper
• Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.

  2016cited by this paper
• Chronic hypoxia facilitates Alzheimer's disease through demethylation of γ‐secretase by downregulating DNA methyltransferase 3b

  2016cited by this paper
• Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.

  2016cited by this paper
• Astrocytes in physiological aging and Alzheimer's disease.

  2016cited by this paper
• Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice

  2016cited by this paper
• The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease

  2016cited by this paper
• Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

  2016cited by this paper
• Mitochondrial Dynamics and Metabolic Regulation.

  2016cited by this paper
• Alzheimer's Disease-Related Misfolded Proteins and Dysfunctional Organelles on Autophagy Menu

  2015cited by this paper
• Cerebral perfusion in the predementia stages of Alzheimer’s disease

  2015cited by this paper
• The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer’s Disease

  2015cited by this paper
• NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases

  2015cited by this paper
• Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.

  2015cited by this paper
• Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1–Regulated Pathways

  2015cited by this paper
• Chronic Intermittent Hypoxia Induces Chronic Low-Grade Neuroinflammation in the Dorsal Hippocampus of Mice.

  2015cited by this paper
• Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer’s Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model

  2015cited by this paper
• Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice

  2015cited by this paper
• Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia*

  2015cited by this paper
• Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism

  2015cited by this paper
• Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

  2015cited by this paper
• CD36 Upregulation Mediated by Intranasal LV-NRF2 Treatment Mitigates Hypoxia-Induced Progression of Alzheimer's-Like Pathogenesis

  2014cited by this paper
• The molecular biology of human iron metabolism.

  2014cited by this paper
• Hypoxia-Induced Tau Phosphorylation and Memory Deficit in Rats

  2014cited by this paper
• Pattern of cerebral hyperperfusion in Alzheimer’s disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience

  2014cited by this paper
• A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis

  2014cited by this paper
• Hypoxia Induces Autophagic Cell Death through Hypoxia-Inducible Factor 1α in Microglia

  2014cited by this paper
• Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease.

  2014cited by this paper
• The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.

  2014cited by this paper
• Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.

  2014cited by this paper
• Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an "iffy" question!

  2013cited by this paper
• Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice

  2013cited by this paper
• Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.

  2013cited by this paper
• The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

  2013cited by this paper
• Type 2 Diabetic and Alzheimer's Disease Mice Present Similar Behavioral, Cognitive, and Vascular Anomalies

  2013cited by this paper
• Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease.

  2013cited by this paper
• Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome

  2013cited by this paper
• Chronic Intermittent Hypoxia Exerts CNS Region-Specific Effects on Rat Microglial Inflammatory and TLR4 Gene Expression

  2013cited by this paper

• Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice

  2026cites this paper
• Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD mice

  2025cites this paper
• Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer’s Disease? A Review of Recent Pertinent Observations from Molecular Biology

  2025cites this paper
• Hypoxia Sensing and Responses in Parkinson’s Disease

  2024cites this paper
• Identification of immunogenic cell death-related genes involved in Alzheimer’s disease

  2024cites this paper
• Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?

  2024cites this paper
• The link between impaired oxygen supply and cognitive decline in peripheral artery disease.

  2023cites this paper
• Intermittent hypoxia protects against hypoxic-ischemic brain damage by inducing functional angiogenesis

  2023cites this paper
• Metabolic Plasticity in Developing and Aging Brain

  2023cites this paper
• An Alternative View of Familial Alzheimer’s Disease Genetics

  2023cites this paper
• Metabolic Plasticity of a Developing and Aging Brain

  2023cites this paper
• Flexible Amortized Variational Inference in qBOLD MRI

  2022cites this paper
• The interplay of hypoxic and mental stress: implications for anxiety and depressive disorders.

  2022cites this paper
• Boosting mitochondrial health to counteract neurodegeneration.

  2022cites this paper